Target intelligence / Profile preview

Long intergenic non-protein coding RNA 620 (LINC00620)

Target
LINC00620
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 620 (LINC00620) is a human long non-coding RNA gene classified as a lincRNA, meaning it is an RNA transcript longer than 200 nucleotides that does not overlap with annotated protein-coding genes and is not translated into protein[1][3][7]. LincRNAs frequently function as regulators of gene expression, chromatin architecture, and transcriptional activity, often with tissue-specific roles in fine-tuning cellular processes[3][7]. There is currently no evidence that LINC00620 encodes a protein or micropeptide, nor has it been implicated as a therapeutic target, biomarker, or drug-interacting molecule in publicly available databases[1]. Its biological and pathological roles remain uncharacterized in the literature indexed by the given results. LINC00620 is a canonical lincRNA with general class-based roles in gene regulation but lacks experimental or clinical association with any disease, drug, or specific biological function to date[1][3][7]. There is nothing incorrect or suspicious about the target name; the main limitation is the current lack of functional or therapeutic evidence.

Other names
LINC00620
02

Biological functions

Gene expression regulationChromatin remodelingRNA stabilizationTranscription regulation

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 620 (LINC00620).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 620 (LINC00620).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call